Having trouble viewing this message? Click here.
Asthma and Allergy Foundation of America Breath eNewsletter
Asthma and Allergy Foundation of America Research Community Asthma and Allergy Foundation of America Subscribe Donate to Asthma and Allergiy Foundation of America

Join Our Webinar About New Peanut Allergy Guidelines

New guidelines recommend early introduction of peanut-containing foods to infants as early as 4 and 6 months of age. How peanut-containing foods should be introduced to infants depends on the infant’s risk level. Join us for a webinar on January 26, 2017 at 3 pm EST to learn more about this topic. AAFA leadership participated in the development of the guidelines.

AAFA Action Alert: Protect Your Health and Keep Access to Health Insurance

Congress is moving forward to repeal the Affordable Care Act (ACA) without a plan in place to ensure that Americans will continue to have access to the health insurance they need. Tell Congress not to repeal the Patient Protection and Affordable Care Act until there is a guarantee that you will still have access to equal or better coverage.

AAFA Names 15 States to 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools

AAFA recently released its 2016 State Honor Roll™ of Asthma and Allergy Policies for Schools (SHR). The report identifies states that make it a priority to create healthy school settings for students with asthma and allergies.

What You Need to Know About Asthma During Pregnancy

Asthma is one of the most common medical problems that occur during pregnancy. Some studies have suggested that asthma complicates up to 7% of all pregnancies. About 30% of all women with asthma report their asthma worsened while pregnant. Visit Living With Asthma: Asthma During Pregnancy to find out more about the right treatment and care for you and your baby.

CVS Health Announces Low-Priced Generic Epinephrine Auto-Injector

CVS Health announced that a low-cost epinephrine auto-injector, the authorized generic for Adrenaclick® manufactured by Impax Laboratories, is available at all CVS Pharmacy locations.

Auvi-Q Coming Back in February 2017

Kaléo, the company that regained the rights to AUVI-Q®, said the epinephrine auto-injector will be available by prescription nationwide on February 14, 2017. Kaléo is also launching AUVI-Q AffordAbility, an access program for AUVI-Q.
How did asthma and allergies affect you today?

AAFA St. Louis’ RESCUE® Program Keeps Kids with Asthma in Class

What happens when a child has an asthma attack while at school? Learn how the Asthma and Allergy Foundation of America, St. Louis Chapter, tackled this issue through a Missouri law and a program to support schools with students from low-income families.

Managing Your Child’s Asthma: Ask the Experts

AAFA is teaming up with Med-IQ, a company that provides continuing medical education to doctors. Together, we’re bringing families an audio-enhanced educational website called Managing Your Child’s Asthma: Ask the Experts. Parents and caregivers can hear asthma experts discussing answers to commonly asked questions about asthma and asthma medicine. The goal is to enhance how families use asthma management plans, improving the long-term health of children.

AAFA's Mission

Student Raises Asthma Awareness Through Senior Project About AAFA

A senior at Plain Dealing High School in Plain Dealing, Louisiana, shows how asthma doesn't have to hold you back from staying active and serving others.

Thank You for Launching Us Into 2017 With a Strong Start

Thanks to donors like you, AAFA is off to a strong start in 2017! Your generous end-of-year donations will support those living with the daily challenges of asthma and allergies. Your support also helps educators, policymakers and caregivers understand the serious issues important to those with asthma and allergies. Thank you!

Thank you for your continued support.
Visit and
Disclaimer: This newsletter is provided to you as a member and subscriber benefit and your use of it is in accordance with our website's terms of service.

Asthma and Allergy Foundation of America makes no representation, whatsoever, for the contents that may be contained in any of the sponsors or advertisers in this newsletter or the quality of any products, information, or other materials displayed, purchased or obtained by you as a result of an offer in connection with any advertisement. 

Please follow the instructions at the bottom of the newsletter to unsubscribe if you no longer wish to be on our newsletter mailing list. This newsletter is sent to all newsletter subscribers and registered members of Asthma and Allergy Foundation of America.

Copyright © 2017 Asthma and Allergy Foundation of America, All rights reserved. ISSN 1939-8166.